Sort   by:  
 Page size 
Proteomicsneonatal rat cardiomyocytes LC-MS/MS
NRCMs were treated with ISO (10 μM) in the presence or absence of FGF18 (50 ng/ml) for 48 h. Protein bands at ~60 kDa were excised from the SDS-PAGE gels for LC-MS/MS analysis
ORGANISM(S): Rattus norvegicus (Rat) 
2023-03-11 | PXD039587 | Pride
Nrcms iso 
UnknownC33(S), a novel PDE9A inhibitor, protects against rat cardiac hypertrophy through upregulating cGMP signaling.
Not available
S-EPMC5589968 | biostudies-literature
UnknownEndophilin A2 attenuates cardiac hypertrophy induced by isoproterenol through the activation of autophagy.
Not available
S-EPMC6731414 | biostudies-literature
UnknownJMJD6 protects against isoproterenol-induced cardiac hypertrophy via inhibition of NF-κB activation by demethylating R149 of the p65 subunit.
Not available
S-EPMC10462732 | biostudies-literature
UnknownMicroRNA-34c-5p provokes isoprenaline-induced cardiac hypertrophy by modulating autophagy via targeting ATG4B.
Not available
S-EPMC9136534 | biostudies-literature
UnknownSZC-6, a small-molecule activator of SIRT3, attenuates cardiac hypertrophy in mice.
Not available
S-EPMC9958013 | biostudies-literature
UnknownVerteporfin Mitigates Isoproterenol-Induced Myocardial Hypertrophy by Attenuating IL-6/STAT3 in Cardiac Fibroblasts.
Not available
S-EPMC12411024 | biostudies-literature
UnknownmiR-145 inhibits isoproterenol-induced cardiomyocyte hypertrophy by targeting the expression and localization of GATA6.
Not available
S-EPMC4183134 | biostudies-literature
UnknownJMJD1A Represses the Development of Cardiomyocyte Hypertrophy by Regulating the Expression of Catalase.
Not available
S-EPMC7243027 | biostudies-literature
UnknownFGF13 Is a Novel Regulator of NF-κB and Potentiates Pathological Cardiac Hypertrophy.
Not available
S-EPMC7567043 | biostudies-literature
Sort   by:  
 Page size